Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer

20081,022 citationsJournal Articlebronze Open Access

Authors

Joseph A. Sparano · Eastern Cooperative Oncology Group

Molin Wang · Eastern Cooperative Oncology Group

Silvana Martino · SWOG Cancer Research Network

Vicky Jones · Leukemia Research Foundation

Edith A. Perez · North Central Cancer Treatment Group

Tom Saphner · Eastern Cooperative Oncology Group

Antonio C. Wolff

Abstract

Weekly paclitaxel after standard adjuvant chemotherapy with doxorubicin and cyclophosphamide improves disease-free and overall survival in women with breast cancer. (ClinicalTrials.gov number, NCT00004125 [ClinicalTrials.gov].).

Topics & Keywords

Cancer Treatment and Pharmacology Breast Cancer Treatment Studies HER2/EGFR in Cancer Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 358, Issue 16, pp. 1663-1671

DOI: 10.1056/nejmoa0707056

Field-Weighted Citation Impact: 32.77